Corporate ActionApr 30, 2026, 06:57 PM
COAG Prices IPO of 16.75M Shares at $18.00; Raises $301.5M
AI Summary
Hemab Therapeutics Holdings, Inc. announced the pricing of its initial public offering of 16,750,000 shares of common stock at $18.00 per share. The offering is expected to generate approximately $301.5 million in gross proceeds, excluding any exercise of the underwriters' option for additional shares. The company's common stock is anticipated to begin trading on the Nasdaq Global Select Market under the ticker "COAG" on May 1, 2026, with the offering expected to close around May 4, 2026.
Key Highlights
- Priced initial public offering (IPO) of 16,750,000 common shares.
- Public offering price set at $18.00 per share.
- Gross proceeds expected to be approximately $301.5 million.
- Underwriters granted 30-day option for up to 2,512,500 additional shares.
- Common stock to trade on Nasdaq Global Select Market under "COAG" from May 1, 2026.
- Offering expected to close on or about May 4, 2026.